Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer

Summary

The goal of this clinical research study is to learn the effectiveness of Sutent® (sunitinib malate, SU011248) in the treatment of patients with non-clear cell renal cell cancer. The safety of sunitinib malate will also be studied.

Timeline

Start

2007-03

Primary completion

2015-03

Completion

2015-03

Drugs

Indications